3 months ago
Recently, a patient with relapsed lymphoma after 5th-line chemotherapy achieved complete remission for over two years through CAR-T therapy, marking one of the longest survivors following the appro...
6 months ago
The latest research on CAR-T Cell AML therapy Groundbreaking News! Dr. Lu Daopu’s Medical Team Publishes Latest Research in Blood Journal: Nanobody-based CD7 CAR-T Therapy for Acute Myeloid L...
6 months ago
Comprehensive Introduction to CAR-T AML Acute Myeloid Leukemia (AML) is one of the most aggressive forms of blood cancer, and its treatment options have historically been limited. However, the adve...
6 months ago
CAR-T Cells Leukemia,Aucatzyl Approved for the Treatment of Relapsed or Refractory B-cell acute Lymphoblastic Leukemia In recent years, the field of oncology has witnessed groundbreaking advancemen...
6 months ago
CAR-T for aml: A Promising Therapeutic Option Acute myeloid leukemia (AML) is a serious and challenging hematological malignancy that demands effective treatment strategies. In this article, we wil...
7 months ago
CAR-T Leukemia: A Revolutionary Approach to Leukemia Treatment Leukemia, a group of blood cancers that primarily affect the bone marrow and lymphatic system, has historically been one of the most c...
8 months ago
**Patient Story: CAR-T Therapy Brings New Hope for Lymphoma Patients – A Case from a Chinese Hospital** Patient Story In the field of cancer treatment, China has achieved groundbreaking success wit...
8 months ago
**China’s CAR-T Therapy Emerging in Glioma Treatment: Neurosurgery Team Wins Three International Awards** Glioma At the recently concluded 76th International Exhibition of Ideas, Inventions, and Ne...
8 months ago
### Exceptional Efficacy of CAR-T Therapy in China: Disease Control Rate for Advanced Liver Cancer Reaches 78% to 91.3% Liver Cancer #CARTTherapy #LiverCancer #SolidTumors In recent years, China ha...
8 months ago
#### New Breakthrough in CAR-T Cell Research in China: Type 2 T Cell Function Supports Long-term Leukemia Remission Leukemia #CAR-T #Leukemia #Type2TCells #ALL #GATA3 In recent years, China has ac...
8 months ago
**Patient Story | Chinese CAR-T Therapy: An Inspiring Journey of Changing Fate for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)** DLBCL #CAR-T #DLBCL #Lymphoma #CA...
8 months ago
### APBMT 2024丨Global Breakthrough of Chinese CAR-T Therapy: New Advances in the Treatment of Central Nervous System Lymphoma (CNSL) CNSL #CAR-T #CNSL #ASCT #APBMT2024 #CARTtherapy #CentralNervous...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
